Device-Aided Therapies for Parkinson ’s Disease: All for One, One for All, That is our Device (Alexandre Dumas)

In this issue of Parkinsonism and Related Disorders, Fernandez and colleagues have conducted a study that used a validated tool to classify PD patients to determine who may benefit from device-aided therapies. The tool, called ‘MANAGE-PD’ used data collected from 563 neurologists on 2709 PD patients already receiving oral therapy and were naïve to device-aided therapies, such as levodopa/carbidopa intestinal gel (LCIG), continuous subcutaneous apomorphine infusion (CSAI), or deep brain stimulation (DBS).
Source: Parkinsonism and Related Disorders - Category: Neurology Authors: Source Type: research